The Online Investor

Slideshow IPOs

By The Online Investor Staff, updated Wed., May. 27, 12:56 PM

Slide #1. Inari Medical, Inc. Initial Public Offering

Company: Inari Medical, Inc.
Proposed Symbol: NARI
Shares Offered: 8,202,565
Price Per Share: $19.00
Over-Allotment: 1,230,384
Description: Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the pricing of its upsized initial public offering of 8,202,565 shares of its common stock at a public offering price of $19.00 per share, for total gross proceeds of approximately $156 million, before deducting underwriting discounts and commissions and offering expenses. All of the shares are being offered and sold by Inari. In addition, Inari has granted the underwriters a 30-day option to purchase up to an additional 1,230,384 shares of common stock at the initial public offering price, less underwriting discounts and commissions. Inari's common stock is expected to begin trading on the Nasdaq Global Select Market on May 22, 2020 under the symbol "NARI." The offering is expected to close on May 27, 2020, subject to the satisfaction of customary closing conditions.

IPOs: Inari Medical, Inc.

List of IPOs in this Slideshow: Company Ticker IPO Date LifeSci Acquisition Corp. LSACU IMARA Inc. IMRA Zentalis Pharmaceuticals, Inc. ZNTL Keros Therapeutics, Inc. KROS Chardan Healthcare Acquisition 2 Corp. CHAQ CC Neuberger Principal Holdings I PCPL.U ORIC Pharmaceuticals, Inc. ORIC Collective Growth Corporation CGROU Live Oak Acquisition Corp. LOAK Sustainable Opportunities Acquisition Corp. SOAC Ayala Pharmaceuticals, Inc. AYLA Kingsoft Cloud Holdings Limited KC ADC Therapeutics SA ADCT B. Riley Principal Merger Corp. II BMRG Inari Medical, Inc. NARI

IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.